Budesonide/formoterol - Intech Biopharm
Alternative Names: SYN 010; SYN010 HFA InhalerLatest Information Update: 31 Oct 2021
At a glance
- Originator Intech Biopharm
- Class Anti-inflammatories; Antiallergics; Antiasthmatics; Bronchodilators; Ethanolamines; Glucocorticoids; Pregnenediones; Small molecules
- Mechanism of Action Beta 2 adrenergic receptor agonists; Glucocorticoid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Asthma; Chronic obstructive pulmonary disease
Most Recent Events
- 05 Aug 2020 Intech Biopharm completes the phase I trial in Asthma (In volunteers) and chronic-obstructive-pulmonary-disease (In volunteers) in Taiwan (Inhalation, Aerosol) (NCT04494321)
- 28 Apr 2019 No recent reports of development identified for phase-I development in Asthma(In volunteers) in Taiwan (Inhalation, Aerosol)
- 28 Apr 2019 No recent reports of development identified for phase-I development in Chronic-obstructive-pulmonary-disease(In volunteers) in Taiwan (Inhalation, Aerosol)